Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2025 Filed May 20, 2025 20:28 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $31.98 | $63,960.00 |
DisclosureSEC source: 0001127602-25-015023 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,255 Read SEC document |
| May 20, 2025 Filed May 20, 2025 20:28 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-015023 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2025 Filed May 16, 2025 20:23 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $30.93 | $154,650.00 |
DisclosureSEC source: 0001127602-25-014700 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,629 Read SEC document |
| May 15, 2025 Filed May 15, 2025 22:51 UTC |
Bhanji MunaDirector
|
SaleCommon Stock | 1,454 | $29.73 | $43,227.42 |
DisclosureSEC source: 0001127602-25-014556 · form4.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,510 Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:42 UTC |
Bhanji MunaDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014365 · form4.xml · derivative · entry 2 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:42 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014365 · form4.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,964 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:40 UTC |
HENDERSON JOHN TDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014364 · form4.xml · derivative · entry 3 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:40 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014364 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,681 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:27 UTC |
Landry Robert EDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014356 · form4.xml · derivative · entry 2 Landry Robert E · CIK 0001585160 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:27 UTC |
Landry Robert EDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014356 · form4.xml · nonDerivative · entry 1 Landry Robert E · CIK 0001585160 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,333 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:35 UTC |
Kaye Edward M. MDDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014360 · form4.xml · derivative · entry 2 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:35 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014360 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,294 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:25 UTC |
WIERENGA WENDALLDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014355 · form4.xml · derivative · entry 2 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:25 UTC |
WIERENGA WENDALLDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014355 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,181 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:23 UTC |
Wysenski NancyDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014354 · form4.xml · derivative · entry 2 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 14, 2025 23:23 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014354 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,610 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 14, 2025 Filed May 15, 2025 22:46 UTC |
PARSHALL B LYNNEDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014552 · form4.xml · derivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 15, 2025 22:46 UTC |
PARSHALL B LYNNEDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014552 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,933 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 14, 2025 Filed May 19, 2025 20:12 UTC |
Harrington Robert ArthurDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 10,880 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014892 · form4.xml · derivative · entry 2 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,880 Underlying: Common Stock · 10,880 shares Expires 2035-05-13 F2 · kind: Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. Read SEC document |
| May 14, 2025 Filed May 19, 2025 20:12 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014892 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,315 F1 · kind: Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting. Read SEC document |
| May 06, 2025 Filed May 6, 2025 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-013482 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2025 Filed May 6, 2025 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $35.01 | $70,020.00 |
DisclosureSEC source: 0001127602-25-013482 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,255 Read SEC document |
| May 06, 2025 Filed May 6, 2025 20:37 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-013482 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2025 Filed May 5, 2025 22:21 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 4,002 | $36.68 | $146,793.36 |
DisclosureSEC source: 0001127602-25-013404 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,687 Read SEC document |
| April 29, 2025 Filed Apr 29, 2025 20:33 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $40.96 | $204,800.00 |
DisclosureSEC source: 0001127602-25-012732 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 417,629 Read SEC document |
| April 22, 2025 Filed Apr 22, 2025 20:33 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-012436 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2025 Filed Apr 22, 2025 20:33 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $38.11 | $76,220.00 |
DisclosureSEC source: 0001127602-25-012436 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,255 Read SEC document |
| April 22, 2025 Filed Apr 22, 2025 20:33 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-012436 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2025 Filed Apr 21, 2025 21:42 UTC |
WIERENGA WENDALLDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001127602-25-012398 · form4.xml · derivative · entry 3 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2025-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 20, 2016. Read SEC document |
| April 21, 2025 Filed Apr 21, 2025 21:42 UTC |
WIERENGA WENDALLDirector
|
SaleCommon Stock | 20,000 | $38.46 | $769,200.00 |
DisclosureSEC source: 0001127602-25-012398 · form4.xml · nonDerivative · entry 2 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,848 Read SEC document |
| April 21, 2025 Filed Apr 21, 2025 21:42 UTC |
WIERENGA WENDALLDirector
|
Exercise / conversionCommon Stock | 20,000 | $6.21 | $124,200.00 |
DisclosureSEC source: 0001127602-25-012398 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:25 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001127602-25-012129 · form4.xml · derivative · entry 4 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2025-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:25 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 3,190 | $38.66 | $123,325.40 |
DisclosureSEC source: 0001127602-25-012129 · form4.xml · nonDerivative · entry 2 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,348 Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:25 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 20,000 | $6.21 | $124,200.00 |
DisclosureSEC source: 0001127602-25-012129 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:07 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 551 | $38.56 | $21,246.56 |
DisclosureSEC source: 0001127602-25-012117 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,348 F1 · kind: Shares acquired pursuant to Director Stock in lieu of Cash Retainer Program. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:04 UTC |
WIERENGA WENDALLDirector
|
GrantCommon Stock | 162 | $38.56 | $6,246.72 |
DisclosureSEC source: 0001127602-25-012113 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,848 F1 · kind: Shares acquired pursuant to Director Stock in lieu of Cash Retainer Program. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:06 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 324 | $38.56 | $12,493.44 |
DisclosureSEC source: 0001127602-25-012115 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,982 F1 · kind: Shares acquired pursuant to Director Stock in lieu of Cash Retainer Plan. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:05 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 324 | $38.56 | $12,493.44 |
DisclosureSEC source: 0001127602-25-012114 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,961 F1 · kind: Shares acquired pursuant to Director Stock in lieu of Cash Retainer Program. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:02 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 162 | $38.56 | $6,246.72 |
DisclosureSEC source: 0001127602-25-012112 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,277 F1 · kind: Shares acquired pursuant to Director Stock in lieu of Cash Retainer Program. Read SEC document |
| April 10, 2025 Filed Apr 10, 2025 21:40 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $36.77 | $183,850.00 |
DisclosureSEC source: 0001127602-25-011922 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,629 Read SEC document |
| April 08, 2025 Filed Apr 8, 2025 22:02 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-011829 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2025 Filed Apr 8, 2025 22:02 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $36.18 | $72,360.00 |
DisclosureSEC source: 0001127602-25-011829 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,255 Read SEC document |
| April 08, 2025 Filed Apr 8, 2025 22:02 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-011829 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2025 Filed Apr 7, 2025 21:03 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,886 | $35.78 | $103,261.08 |
DisclosureSEC source: 0001127602-25-011767 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,689 Read SEC document |
| April 03, 2025 Filed Apr 4, 2025 20:10 UTC |
Harrington Robert ArthurDirector
|
SaleCommon Stock | 450 | $39.43 | $17,743.50 |
DisclosureSEC source: 0001127602-25-011689 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,658 Read SEC document |
| March 31, 2025 Filed Mar 31, 2025 20:28 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 15,000 | $40.75 | $611,250.00 |
DisclosureSEC source: 0001127602-25-010672 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 427,629 Read SEC document |
| March 19, 2025 Filed Mar 19, 2025 22:03 UTC |
Malik Fady IbrahamEVP Research & Development
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010043 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,255 F1 · kind: bona fide third party donation. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 20:29 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001127602-25-009780 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,105 Underlying: Common Stock · 2,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 20:29 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $43.58 | $87,160.00 |
DisclosureSEC source: 0001127602-25-009780 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,455 Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 20:29 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 2,000 | $10.60 | $21,200.00 |
DisclosureSEC source: 0001127602-25-009780 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.